Skip to main content
28 March 2024
Last updated:
Tuesday 26 March 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
European biotechs rise in March quarter
Read more
The case for allogeneic cell therapy
Read more
Clinical and market issues for cell-based therapies
Read more
Checkpoint inhibitors - A new horizon for cancer therapy
Read more
Will scanners be the key to translational medicine?
Read more
Why the time has come for MidPharmas
Read more
Alkermes pioneers trial design in depression
Read more
The EU Clinical Trials Regulation: Legislators see light at the end of the tunnel
Read more
Oncology Development Review - 2013: Competition for new cancer treatments intensifies
Read more
Commentary: The outlook for biotech seems rosy - for now
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
49
Page
50
Page
51
Page
52
Current page
53
Page
54
Page
55
Page
56
Page
57
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form